SCHEMBL23905385

SCHEMBL23905385

CC1(CI)COc2c1cc(Cl)nc2-c1ccc(F)c(F)c1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905386 0.90 PGR (0.33) PGR
SCHEMBL23905441 0.89 PGR (0.32) PGR
SCHEMBL23883058 0.83
SCHEMBL23905383 0.82 MEN1 (0.33) PGR
SCHEMBL23904878 0.73 ADORA2A (0.35)
SCHEMBL23905717 0.71 ADORA2A (0.33)
SCHEMBL23905730 0.70
SCHEMBL24345285 0.70 ADORA2A (0.43)
SCHEMBL24345265 0.70 ADORA2A (0.43)
SCHEMBL23905585 0.68 ADORA2A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed